MYC and breast cancer: Thus, the tested MI products were investigated in their ability to influence: (i) tumor cell proliferation and viability in a three-dimensional (3D) model of CRC cells, (ii) the clonogenic capacity of PC and BC cell lines, (iii) C-MYC expression and the M2c/M1-like switch in phenotype in human peripheral blood mononuclear cells (PBMCs)-derived macrophages.